Wellington Management

lighthouse in stormy night

Biotech

Gene therapy biotech secures $150M for eye disease candidates

Atsena has raised $150 million to advance its gene therapy designed to reverse or prevent blindness.

Gabrielle Masson Apr 2, 2025 7:30am

power lines at dusk

Novo Holdings-backed SiteOne charges up with $100M financing

Dec 18, 2024 7:00am